Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/mp.2017.40 http://scihub22266oqcxt.onion/10.1038/mp.2017.40 C5582162!5582162 !28322279     free     free     free Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\28322279 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Mol+Psychiatry 2017 ; 22 (9 ): 1241-1249 Nephropedia Template TP {{tp|p=28322279 |t=2017. Pluripotent stem cells in neuropsychiatric disorders |pdf=|usr=}}{{28322279 }} gab.com Text Pluripotent stem cells in neuropsychiatric disorders JO: Mol Psychiatry http://www.kidney.de/pget.php?&tw=1&pmid=28322279 #FOAvip Neuropsychiatric disorders place an enormous medical burden on patients across all social and economic ranks. The current understanding of the molecular and cellular causes of neuropsychiatric disease remains limited, which leads to a lack of targeted therapies. Human-induced pluripotent stem cell (iPSC) technology offers a novel platform for modeling the genetic contribution to mental disorders and yields access to patient-specific cells for drug discovery and personalized medicine. Here, we review recent progress in using iPSC technology to model and potentially treat neuropsychiatric disorders by focusing on the most prevalent conditions in psychiatry, including depression, anxiety disorders, bipolar disorder and schizophrenia. Twit Text FOAVip Pluripotent stem cells in neuropsychiatric disorders ????Mol Psychiatry http://www.kidney.de/pget.php?&tw=1&pmid=28322279 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28322279 #FOAvip English Wikipedia <ref>{{Cite pmid|28322279 }}</ref> Pluripotent stem cells in neuropsychiatric disorders #MMPMID28322279 Soliman MA ; Aboharb F ; Zeltner N ; Studer L Mol Psychiatry 2017[Sep]; 22 (9 ): 1241-1249 PMID28322279 show ga Neuropsychiatric disorders place an enormous medical burden on patients across all social and economic ranks. The current understanding of the molecular and cellular causes of neuropsychiatric disease remains limited, which leads to a lack of targeted therapies. Human-induced pluripotent stem cell (iPSC) technology offers a novel platform for modeling the genetic contribution to mental disorders and yields access to patient-specific cells for drug discovery and personalized medicine. Here, we review recent progress in using iPSC technology to model and potentially treat neuropsychiatric disorders by focusing on the most prevalent conditions in psychiatry, including depression, anxiety disorders, bipolar disorder and schizophrenia. |Bipolar Disorder/metabolism [MESH] |Humans [MESH] |Induced Pluripotent Stem Cells [MESH] |Mental Disorders/*physiopathology/*therapy [MESH] |Pluripotent Stem Cells/*metabolism/physiology [MESH] |Precision Medicine/psychology [MESH]Pluripotent stem cells in neuropsychiatric disorders (epmc).pdf DeepDyve Pubget Overpricing